TCM
CCEL icon

Topline Capital Management’s Cryo-Cell International CCEL Stock Holding History

Topline Capital Management’s Portfolio CCEL Stock Details CCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-40,553
Closed -$210K – 44
2025
Q2 		$210K Sell
40,553
-7,238
-15% -$38.2K 0.04% 36
2025
Q1 		$304K Hold
47,791
– – 0.07% 36
2024
Q4 		$354K Buy
+47,791
New +$360K 0.07% 34

Other funds holding CCEL

HLA
Hamilton Lane Advisors Conshohocken, Pennsylvania $149M AUM 14.17% 1-Year Est. Return
SA
SFI Advisors Montclair, New Jersey $95.2M AUM 23.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Topline Capital Management's CCEL Position: Q3 2025 in Review

Topline Capital Management sold out of Cryo-Cell International (CCEL) in Q3 2025, closing a stake of 40,553 shares — an estimated $210K sold.

Topline Capital Management first reported a position in CCEL in Q4 2024 and held it in 3 quarters. The position peaked at $354K in Q4 2024. 20 funds tracked by Wall St. Rank hold CCEL as of Q3 2025.

  • Topline Capital Management reported no remaining Cryo-Cell International position as of Q3 2025 after selling out during the quarter.
  • Topline Capital Management sold 40,553 Cryo-Cell International shares in Q3 2025, an estimated $210K.
  • Topline Capital Management first reported a position in Cryo-Cell International in Q4 2024 and held it in 3 quarters.
  • Topline Capital Management's Cryo-Cell International position peaked at $354K in Q4 2024.
  • 20 funds tracked by Wall St. Rank held Cryo-Cell International as of Q3 2025.

Based on Topline Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.